Correlation Between MAIA Biotechnology and Olema Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Olema Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Olema Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Olema Pharmaceuticals, you can compare the effects of market volatilities on MAIA Biotechnology and Olema Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Olema Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Olema Pharmaceuticals.
Diversification Opportunities for MAIA Biotechnology and Olema Pharmaceuticals
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between MAIA and Olema is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Olema Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Olema Pharmaceuticals and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Olema Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Olema Pharmaceuticals has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Olema Pharmaceuticals go up and down completely randomly.
Pair Corralation between MAIA Biotechnology and Olema Pharmaceuticals
Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 0.94 times more return on investment than Olema Pharmaceuticals. However, MAIA Biotechnology is 1.06 times less risky than Olema Pharmaceuticals. It trades about -0.05 of its potential returns per unit of risk. Olema Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest 251.00 in MAIA Biotechnology on October 25, 2024 and sell it today you would lose (56.00) from holding MAIA Biotechnology or give up 22.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MAIA Biotechnology vs. Olema Pharmaceuticals
Performance |
| Timeline |
| MAIA Biotechnology |
| Olema Pharmaceuticals |
MAIA Biotechnology and Olema Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MAIA Biotechnology and Olema Pharmaceuticals
The main advantage of trading using opposite MAIA Biotechnology and Olema Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Olema Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Olema Pharmaceuticals will offset losses from the drop in Olema Pharmaceuticals' long position.| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |